Haleon (NYSE: HLN) publishes updated £10,000,000,000 EMTN listing particulars

Rhea-AI Filing Summary

Haleon plc has published updated listing particulars for Haleon UK Capital plc’s and Haleon Netherlands Capital B.V.’s £10,000,000,000 Euro Medium Term Note (EMTN) Programme, which is guaranteed by Haleon. This is described as a routine annual update. The listing particulars, dated 7 May 2026, are available to download from Haleon’s investor debt section online.

The EMTN programme provides a framework under which the group can issue debt securities in the future, subject to applicable terms and investor eligibility set out in the listing particulars.

Key Figures

EMTN Programme Size: £10,000,000,000 Listing particulars date: 7 May 2026

2 metrics

EMTN Programme Size £10,000,000,000 Maximum aggregate size of Haleon EMTN Programme in listing particulars dated 7 May 2026

Listing particulars date 7 May 2026 Date of updated listing particulars for EMTN programme

Key Terms

Euro Medium Term Note (EMTN) Programme, Listing Particulars, guaranteed by the Company, foreign private issuer

4 terms

Euro Medium Term Note (EMTN) Programme financial

"£10,000,000,000 Euro Medium Term Note ("EMTN") Programme, guaranteed by the Company"

A euro medium term note (EMTN) programme is a legal arrangement that lets a borrower issue multiple debt notes over time under one set of paperwork, often in euros but sometimes in other currencies and with different maturities. Think of it like a single menu of IOUs an issuer can use as needed; it matters to investors because it creates a steady supply of bonds with varying terms, so buyers can pick maturity and yield that fit their risk, return and liquidity needs.

Listing Particulars regulatory

"listing particulars dated 7 May 2026 ... have been published (the "Listing Particulars")"

guaranteed by the Company financial

"£10,000,000,000 Euro Medium Term Note ("EMTN") Programme, guaranteed by the Company"

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	07 May 2026 - “EMTN programme publication of listing particulars”

99.1

Haleon plc: EMTN programme - Publication of listing particulars

7 May 2026: Haleon plc (the "Company" or "Haleon") announces that, following a routine annual update, listing particulars dated 7 May 2026 regarding Haleon UK Capital plc's and Haleon Netherlands Capital B.V.'s £10,000,000,000 Euro Medium Term Note ("EMTN") Programme, guaranteed by the Company, have been published (the "Listing Particulars").

A copy of the Listing Particulars is available for inspection and can be downloaded from www.haleon.com/investors/debt-investors.

Amanda Mellor

Company Secretary

Enquiries

Investors		Media
Jo Russell	+44 7787 392441	Zoë Bird	+44 7736 746167
Rakesh Patel	+44 7552 484646	Victoria Durman	+44 7894 505730
Email: investor-relations@haleon.com		Email: corporate.media@haleon.com

About Haleon

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.

For more information, please visit www.haleon.com. 

Disclaimer

Please note that the information contained in the Listing Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Listing Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Listing Particulars is not addressed. Prior to relying on the information contained in the Listing Particulars, you must ascertain from the Listing Particulars whether or not you are part of the intended addressees of the information contained in the Listing Particulars.

Your right to access this service is conditional upon complying with the above requirement.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: May 07, 2026	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

FAQ

What did Haleon plc (HLN) announce in its May 2026 Form 6-K?

Haleon announced the publication of updated listing particulars for its £10,000,000,000 Euro Medium Term Note programme. The update is described as a routine annual refresh and covers notes issued by Haleon UK Capital plc and Haleon Netherlands Capital B.V., guaranteed by Haleon.

What is the size of Haleon’s Euro Medium Term Note (EMTN) programme?

Haleon’s EMTN programme has a maximum aggregate size of £10,000,000,000. This programme allows Haleon UK Capital plc and Haleon Netherlands Capital B.V., with a guarantee from Haleon plc, to issue debt securities within that overall limit as described in the listing particulars.

Who issues and who guarantees the notes under Haleon’s EMTN programme?

Notes under the EMTN programme may be issued by Haleon UK Capital plc and Haleon Netherlands Capital B.V. These notes are guaranteed by Haleon plc, meaning Haleon stands behind the obligations described in the programme’s listing particulars, subject to the detailed terms contained in that document.

Where can investors access Haleon’s EMTN listing particulars?

Investors can access and download the listing particulars from Haleon’s website at www.haleon.com/investors/debt-investors. The document contains detailed terms of the £10,000,000,000 EMTN programme and information on who the intended addressees of the offer and disclosures are.

Is Haleon’s EMTN listing information intended for all investors globally?

No, the listing particulars may be addressed to residents of specific countries only. The document states that individuals must confirm from the listing particulars whether they are among the intended addressees before relying on the information or any offer described in the EMTN programme.

Does this EMTN update mean Haleon is issuing new debt now?

The document states that Haleon has published updated listing particulars for its £10,000,000,000 EMTN programme following a routine annual update. It describes the programme framework and terms, rather than announcing a specific new note issuance or individual transaction within the programme.